Clinical Trial Update: A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a single-dose nevirapine regimen combined with Combivir for the prevention of mother-to-child transmission of HIV has completed. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Acquired Immunodeficiency Syndrome | Phase 3 | Status: COMPLETED